Clinical Diagnostic

Enquiry IconContact Us

Increasing patient awareness and rising demand for high quality care have made it imperative for healthcare providers to develop targeted therapies through specific and sensitive diagnostic tests. Clinical diagnostic tests are used to diagnose a medical condition, provide information about the patient’s health, or monitor a course of disease and assess the patient’s response to treatments. Various techniques of clinical diagnostic testing include blood gas testing, clinical chemistry, immunoassay, coagulation testing, hematology, polymerase chain reaction (PCR), and staining method.

Typically, clinical diagnostic tests involve use of antibody-based techniques for recognizing proteins or disease markers. However, these immunoassays cannot identify all biomarkers in one test and are prone to false-positive and false-negative results. Therefore, there is growing demand for more accurate, efficient, and reliable technologies. This has led to development of alternative testing methods such as LC-MS and GC-MS. However, high initial capital investment and lack of skilled labor is deterring adoption of advance testing devices. Major instruments used in clinical diagnostics include immunoassay analyzer, HPLC system, chemical analyzer, mass spectrometer (MS), LC-MS, and GC-MS. The use of reagents has simplified the testing practice and workflow for personnel in diagnostic laboratories.

New Techniques in Use

Molecular diagnostics is driving growth of the personalized medicine market which involves co-development of drugs/devices and specialized diagnostic tests. The technique is also referred to as companion diagnostic and can be used for toxicity studies, dose selection, monitoring patient response, and patient stratification.

Rapid diagnostic tests are performed at the physician office laboratory (POL), hospitals, health centers and home care. Demand for these tests is increasing rapidly owing to faster and accurate results. Tests have been developed for HbA1c testing, drug abuse, pregnancy testing, micro albumin, creatinine, blood gases, RSV, etc.

Demand for In-vitro diagnostics (IVD) is increasing in emerging markets such as India, China, Brazil, and South Korea. In-vitro diagnostic techniques have transformed the diagnostics industry by eliminating the complex in-vivo testing methods. The IVD techniques include the advance PCR technique, assays and hematology testing, helps diagnose and monitor patient’s health condition using samples of blood, cells or tissues.

Immunoassay diagnostics is expected to be driven by technological advancements such as novel biomarkers, ultrasensitive detection system and assays.

Fragmented Market

The diagnostic landscape, especially in the emerging countries, is highly fragmented and marked by the strong presence of unorganized diagnostic labs. Global players are now building global networks by investing in foreign markets. Moreover, in terms of manufacturers, the market is fragmented in a similar manner with many small players dominating local markets. Owing to the increasing demand for home care, manufacturers and diagnostic laboratories need to work in collaboration to provide quality care at patient convenience.

Conclusion

Increasing healthcare costs is deterring patients from undergoing regular health tests that can be improved with a wider insurance coverage. Inadequate insurance coverage in emerging economies is restricting patients from undergoing expensive health tests, thus fueling the market growth. Moreover, centralization of testing laboratories is projected to drive demand for high volume instrumentation and automation equipment. Demand for IVD tests from Asia Pacific, Latin America and the Middle East markets is also increasing rapidly.

View More

Clinical Diagnostic Published Insights

Coherent Market Insights

Malaria Diagnostics Market, By Technology (Microscopy, Rapid Diagnostic Tests, Molecular Diagnostic Tests, and Other Technologies) and By Geography (Americas, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published Date : Jul 2022

Malaria is a disease caused by a parasite. The parasite is spread to humans through the bites of infected mosquitoes. Malaria is still common in tropical and subtropical countries. If diagnosed early and if the appropriate antimalarials are available and used, the pro... View more

Coherent Market Insights

Colorectal Cancer Screening Market, By Screening Tests (Stool-based Tests, Colonoscopy, CT Colonography (Virtual Colonoscopy), Flexible Sigmoidoscopy, and Other Screening Tests), By End User (Hospitals Independent Diagnostic Labs and Other End Users), and By Geography (North America, South America, Europe, Asia-Pacific, and Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published Date : Jul 2022

Colorectal cancer, or colon cancer, is a type of cancer that begins in the large intestine (colon). The colon is the final part of the digestive tract. The cancer often begins as a growth called a polyp inside the colon or rectum. Finding and removing polyps can preve... View more

Coherent Market Insights

North Africa Non-Invasive Prenatal Testing Market, By Application (Trisomy, Microdeletion Syndrome, Sex Chromosome Abnormalities, Others), By End User (Hospitals, Diagnostic Centers & Independent Laboratories), By Country (Egypt, Algeria, Morocco, and Rest of North Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published Date : Feb 2022

Noninvasive prenatal testing (NIPT) is an evolving screening procedure for pregnant women. It examines cell free Deoxyribonucleic Acid (DNA) of both fetus and the mother. It provides an analysis of genetic screening using only one tube blood. NIPT provides predictions... View more

Coherent Market Insights

Polyclonal Antibody Market, by Type (Primary Antibody and Secondary Antibody), by Application (Academic Research and Commercial), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published Date : Dec 2020

Polyclonal antibodies are a heterogeneous mix of antibodies derived from the immune response of multiple B-cells, in which each one recognizes a different epitope on the same antigen. Polyclonal antibodies are composed of a mixture of antibodies that represent the nat... View more

Coherent Market Insights

Ophthalmoscopes Market, by Product Type (Direct Inspection and Indirect Inspection), by End User (Hospitals, Eye Clinics, and Ambulatory Surgical Centers), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published Date : Sep 2020

Technological advancements in the disease diagnostic field has led to advanced product development. Key manufacturers are focused on developing new ophthalmoscopes for unmet need of ophthalmic diagnostic practices. The increasing product launches by key players is exp... View more

Coherent Market Insights

Chromatography Market, By Product Type (Liquid (HPLC, UHPLC), Gas Liquid, Others (Ion Chromatography, LPLC, Flash, TLC and Chemical sensors)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published Date : Aug 2020

Chromatography is widely used in various life science applications. It finds application in the food industry for spoilage detection, additive detection, and determining nutritional quality. In forensics, it is used for crime scene testing and forensic pathology. ... View more

Coherent Market Insights

Cervical Cancer Diagnostic Tests Market, By Test Type (Pap Smear Test, Colposcopy Test, ECC Test, and HPV Test), By Age Group (Age 20 – 40 and Age Above 40), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published Date : Mar 2021

Cervical cancer occurs in the cells of the cervix. Pap smear, colposcopy, and ECC test are performed for the diagnosis of cervical cancer. Increasing awareness regarding cervical cancer and increasing prevalence of cervical cancer in emerging economies are expected to... View more

Coherent Market Insights

Diagnostic Testing of STDs Market, By Test Type (Chlamydia, Gonorrhea, Syphilis, HIV, HPV+pap smear, HSV, Chancroid), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published Date : Jun 2020

Sexually Transmitted Diseases (STDs) are diseases that spread primarily through person-to-person sexual contact. Early identification or diagnosis of STDs and partner notification can help halt further transmission. Statist... View more

Coherent Market Insights

In Vitro Toxicity Testing Market, By Type (Absorption, Toxic Substances, Dose), By End User (Cosmetics And Household Products, Pharmaceutical Industry, Food Industry, Chemicals Industry), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published Date : May 2020

In vitro toxicology testing is used to examine the toxic properties of compounds and mixtures on cultured bacteria or mammalian cells. ADME and toxicological profiling plays a major role in drug develop... View more

Subscribe Newsletter

Kindly subscribe for our latest news & articles.